January 2024
A few months ago, in one of the last DYSL Pierre-Emmanuel Gerard, presented the key issues of BIOMUNEX PHARMACEUTICALS.
Very happy to share today this excellente news for the development of #Biomunex.
For more than 5 years, with one of our key Expert-in-Residence, Stéphane MILOT, with Loïc MOULARD also for a few months, at the helm of the outsourced Financial Department, as well as our support around different strategic and operational perspectives, #LallianSe is pleased to contribute to the success of Biomunex.
Congratulations to the entire team for starting this clinical study ! 👏
Find out more👉 https://lnkd.in/eH47-xeJ
#Partnership #innovation #biotech #healthcare #immunotherapy #XIR